Skip to main content

. 1953 Dec 19;2(4850):1341–1345. doi: 10.1136/bmj.2.4850.1341

L-Noradrenaline in Treatment of Shock in Cardiac Infarction

K Shirley Smith, A Guz

PMCID: PMC2030354 PMID: 13106425

1341

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

BURN J. H., HUTCHEON D. E. The action of noradrenaline. Br J Pharmacol Chemother. 1949 Dec;4(4):373–380. doi: 10.1111/j.1476-5381.1949.tb00564.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
KURLAND G. S., MALACH M. The clinical use of norepinephrine in the treatment of shock accompanying myocardial infarction and other conditions. N Engl J Med. 1952 Sep 11;247(11):383–389. doi: 10.1056/NEJM195209112471102. [DOI] [PubMed] [Google Scholar]
MILLER A. J., BAKER L. A. 1-Arterenol (levophed) in the treatment of shock due to acute myocardial infarction. AMA Arch Intern Med. 1952 Apr;89(4):591–599. doi: 10.1001/archinte.1952.00240040070009. [DOI] [PubMed] [Google Scholar]
REALE A., KAPPERT A., SKOGLUND C. H., SUTTON G. C. The effect of l-nor-adrenaline on the oxygen consumption of human beings. Acta Physiol Scand. 1950 Mar 27;20(2-3):153–159. doi: 10.1111/j.1748-1716.1950.tb00693.x. [DOI] [PubMed] [Google Scholar]
SWAN H. J. C. Noradrenaline, adrenaline, and the human circulation. Br Med J. 1952 May 10;1(4766):1003–1006. doi: 10.1136/bmj.1.4766.1003. [DOI] [PMC free article] [PubMed] [Google Scholar]
WIGGERS C. J. The functional importance of coronary collaterals. Circulation. 1952 Apr;5(4):609–615. doi: 10.1161/01.cir.5.4.609. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES